Drusilla Scott

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Carlos M. Barrera, Analía Mykietiuk, Hristo Metev et al. · The Lancet Infectious Diseases · 2016 · 101 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

David Oldach, Kay Clark, Jennifer Schranz et al. · Antimicrobial Agents and Chemotherapy · 2013 · 78 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +13

Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects

James Still, Jennifer Schranz, Thorsten P. Degenhardt et al. · Antimicrobial Agents and Chemotherapy · 2011 · 63 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure.

H M Anthony, Alan J. Mearns, M. K. Mason et al. · Thorax · 1979 · 62 citations · Full text

Medicine, Oncology, Pharmacology +8

A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

J. Carl Craft, Susan Moriarty, Kay Clark et al. · Clinical Infectious Diseases · 2011 · 46 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13